MEDICE

What MEDICE does

MEDICE, legally structured as MEDICE Arzneimittel Pütter GmbH & Co. KG and operating under the brand "MEDICE Health Family," is a German family-owned pharmaceutical company founded in 1949 and headquartered in Iserlohn. The company employs 501–1,000 people and operates a multimodal health solutions platform that combines three product categories: pharmacological drug therapies, evidence-based digital treatments, and nutrition concepts. Its mission, as stated in source material, is to reduce care gaps and improve patient outcomes across all illness phases by integrating these three modalities, framed within a broader health philosophy encompassing physical/psychological, social, and ecological well-being.

The product portfolio centers on prescription pharmaceutical therapies distributed through German healthcare providers (doctors, pharmacists, and pharmacy technicians), supplemented by two digital health assets: the femfeel menopause support app acquired in October 2023, which provides content, symptom tracking, and lifestyle courses, and a prescribable VR-based digital health application (DiGA) for pediatric ADHD under co-development with Brainjo targeting 2028 approval. A direct-to-consumer Health Family Shop sells sustainable, bio-quality nutrition products online. The June 2026 strategic licensing agreement with HMNC Brain Health adds exclusive European commercialization rights to Ketabon (KET01), a treatment for treatment-resistant depression, alongside tiered double-digit royalties and success-based milestones.

The revenue model is multi-streamed: traditional one-time prescription pharmaceutical sales, recurring revenue from digital health applications (femfeel subscription and forthcoming Brainjo DiGA), direct consumer hardware/sales through the e-commerce shop, and licensing royalties from the HMNC KET01 partnership. Go-to-market is hybrid — sales-led through healthcare providers for pharmaceuticals, with an emerging D2C e-commerce channel for nutrition. Geographic footprint remains primarily German/European, with no global claim made in the materials.

Name

MEDICE

Legal name

MEDICE Arzneimittel Pütter GmbH & Co. KG

Website

https://medice.com

Company type

Private

Founded year

1949

Operating status

Operating

Headcount range

501–1,000 employees

Short description

MEDICE is a German family-owned pharmaceutical company founded in 1949 that combines drug therapies, evidence-based digital treatments, and nutrition concepts into multimodal health solutions, serving patients and healthcare providers across Germany and Europe.

Ownership category

akta.pro rank

Product category

Pharmaceuticals

NAICS

Pharmaceutical and Medicine Manufacturing (32541), Pharmacies and Drug Retailers (45611)

SIC

Pharmaceutical Preparations (2834), Retail-Drug Stores And Proprietary Stores (5912)

akta.pro primary industry

Chronic Condition Medication Programs (e.g., diabetes, hypertension) with Integrated Prescribing (HLALAIAH)

akta.pro secondary industries

Medication Adherence, Reminders & Patient Support (HLACAKAF), Health, Wellness & Pharmacy Marketplaces (CRAFABAF)

Keywords

• Pharmaceutical medicines
• Digital health treatments
• Nutrition concepts
• Healthcare provider distribution
• Multimodal health solutions

Headquarters

HQ city

Iserlohn

HQ country

Germany

HQ region

Europe

Offices1 record

Markets served

GTM type

B2B and B2C

Offering type

Hardware or Manufacturing

Cost components

Personnel, Operations, Technology or R&D, Marketing or Sales, Supply Chain, Infrastructure

Revenue model

1. Pharmaceutical Drug Therapies: Traditional pharmaceutical products including drug therapies for various therapeutic areas. Core revenue stream from prescription medications.
2. Digital Health Solutions: Evidence-based digital treatments including the femfeel app for menopause support and VR-based therapies through partnerships.
3. Nutrition Concepts and Products: Health and wellness products sold through the Health Family Shop, including bio-quality and sustainable products.
4. Licensing and Royalties: MEDICE receives tiered double-digit royalties on net sales and success-based commercial milestone payments from its licensing agreement with HMNC Brain Health for European commercialization rights to KET01.

Go-to-market motion1 record

Distribution channels3 records

Marketing channels4 records

Core offering

MEDICE develops, manufactures, and distributes multimodal health solutions that combine pharmacological drug therapies, evidence-based digital treatments, and nutrition concepts to support patients across all phases of illness. The company sells prescription pharmaceutical products through doctors, pharmacists, and pharmacy technicians in Germany, operates a direct-to-consumer e-commerce shop (Health Family Shop) for sustainable nutrition and wellness products, and has expanded into digital therapeutics such as the FemFeel menopause-support app (acquired October 2023) and a VR-based ADHD therapy app under development with Brainjo.

Product overview

MEDICE Health Family operates as a multimodal health solutions platform combining pharmaceutical drug therapies, evidence-based digital treatments, and nutrition concepts. The portfolio includes the core Health Solutions Platform delivering integrated patient care, the FemFeel app (acquired 2023) providing digital menopause support with symptom tracking and lifestyle courses, and the Health Family Shop offering sustainable organic health products. The company structures its approach around three health dimensions: physical/psychological, social, and ecological health, with the mission to improve patient care across all phases of illness.

Differentiator

Problem solved

Functional benefit

Products and services

• FemFeel App Digital platform supporting women through menopause by providing informational content, complaint tracking, and lifestyle adjustment courses designed to improve well-being across phases of menopause.
• Health Family Shop Direct-to-consumer e-commerce platform offering sustainable, organic health products with bio-quality focus, delivered to consumers with multiple payment options including PayPal, Klarna, SEPA, credit cards, and Apple Pay.

Quantifiable outcome

• Strengthened role in digital health and enhanced patient care through femfeel acquisition

Segments2 records

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Integration5 records

Feature2 records

Partnerships

Three partnerships are on record, tiered flagship and core.

• HMNC Brain HealthflagshipStrategic or Co-development Partner · 15 June 2026MEDICE served as the lead investor in HMNC Brain Health's $50 million Series B first closing. Concurrently, MEDICE entered a strategic licensing agreement for exclusive European commercialization rights to Ketabon (KET01), a treatment for treatment-resistant depression, with tiered double-digit royalties and success-based commercial milestone payments. This partnership extends MEDICE's neuroscience pipeline and creates a deeper strategic relationship.
• BrainjocoreStrategic or Co-development Partner · 23 April 2026Brainjo, a Regensburg healthtech startup founded in 2022, developed a prescribable VR-based digital health app (DiGA) for children with ADHD in partnership with MEDICE. The platform translates validated therapy tasks into virtual environments. Brainjo closed a €2 million seed round led by High-Tech Gründerfonds. MEDICE's partnership involves co-development of the platform and clinical validation toward DiGA approval by 2028.
• Femfeel AppcoreTechnology or Integration · 10 October 2023MEDICE acquired the femfeel app, a digital platform supporting women through menopause launched in 2020. The app provides informational content, complaint tracking, and lifestyle adjustment courses. The acquisition strengthens MEDICE's digital health offerings and enhances patient care through expanded digital treatment capabilities.

Scale indicators2 records

Recent moves4 records

Expansion highlights6 records

Broad incumbents

• Stada Arzneimittel AG: Largest German specialty and generics pharmaceutical company with broad European distribution to doctors and pharmacists. Comparable to MEDICE as a German pharma incumbent pursuing a hybrid pharma + consumer health model, though materially larger in scale and product breadth.
• Merz Therapeutics GmbH: German family-owned pharmaceutical company with strong CNS/neurology franchises and consumer aesthetics. Comparable to MEDICE as a German family-owned pharma with overlapping therapeutic areas (CNS) and pharmacy-led distribution.
• Bayer Consumer Health: Global incumbent with a substantial German pharma and consumer health franchise, including OTCs and digital health pilots. Comparable as a broad incumbent competing with MEDICE in German pharmacy shelves and selected digital therapeutic initiatives.

Direct peers

• Dermapharm Holding SE: German mid-sized pharmaceutical manufacturer (~1,000+ employees) with a focus on branded generics and OTC products distributed via German pharmacies. Closely matches MEDICE in size, business model (branded pharma via pharmacy channel), and German-centric GTM.
• neuraxpharm Arzneimittel GmbH: Germany-based CNS specialty pharmaceutical company. Highly comparable to MEDICE given MEDICE's exclusive European rights to KET01 (a CNS depression treatment), and the shared focus on branded specialty pharma distributed via German prescribers and pharmacies.
• Desitin Arzneimittel GmbH: Hamburg-based German specialty pharmaceutical company focused on neurology, psychiatry, and pain therapies. Direct comparable in therapeutic area alignment (CNS) and German mid-sized pharma profile mirroring MEDICE's positioning.
• Dr. Willmar Schwabe GmbH & Co. KG: Family-owned German pharmaceutical company specializing in phytopharmaceuticals and self-care products. Comparable to MEDICE as a long-established family-owned German pharma with both prescription and consumer health lines.
• Biologische Heilmittel Heel GmbH: German family-owned pharmaceutical company producing combination biologic medicines with global distribution. Comparable to MEDICE in family-ownership structure, German origin, and a multimodal therapeutic portfolio.
• Krewel Meuselbach GmbH & Co. KG: German family-owned OTC and pharmaceutical company selling through pharmacies. Highly comparable to MEDICE's pharmacy-channel-led pharma + consumer health hybrid model in a similar mid-sized German footprint.

Emerging players

• Selfapy GmbH: Berlin-based digital therapeutics company with approved DiGAs for mental health conditions. Comparable to MEDICE's femfeel and Brainjo digital health initiatives as a peer in the German reimbursed digital therapeutics space MEDICE is targeting.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat4 records

Key risks5 records

Key highlights6 records

Customer concentration

• Facebookfacebook.com/MediceArzneimittel
• LinkedInlinkedin.com/company/medice-arzneimittel
• Instagraminstagram.com/medice/?hl=de

Revenue estimate

Valuation estimate

Number of profiles

Subsidiaries1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A1 record

Investments1 record

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about MEDICE